Skip to main content

Enhancing stress reactivity and wellbeing in early schizophrenia: A randomized controlled trial of Integrated Coping Awareness Therapy (I-CAT)

September 13, 2021

Discriminatory experiences predict neuroanatomical changes and anxiety among healthy individuals and those at clinical high risk for psychosis

September 13, 2021
Individuals face discrimination and discriminatory experiences (DE) based on characteristics including race/ethnicity, gender, age, and disability. This report assessed whether lifetime DE are associated with changes in brain structure (e.g. cortical thinning) and clinical outcomes across time. This report provides the first evidence to date of an association between DE...

A Clinical Brexanolone Treatment Program at an Academic Medical Center- challenges and lessons learned with patient selection and post 30 day outcomes

September 13, 2021
Brexanolone (Zulresso) is the first Federal Drug Administration (FDA) approved drug for the treatment of postpartum depression (PPD). Brexanolone is a positive allosteric modulator of the GABAA receptor, and is given over 60 hours by infusion in a medical setting. This drug has been shown to be effective at significantly reducing...

Dr. Nadia Charguia shares 6 tips for healthcare workers facing burnout while speaking with UNC Health Talk

September 10, 2021

Duke, UNC Awarded Grant to Establish Joint Alzheimer’s Disease Research Center, Chair Dr. Samantha Meltzer-Brody collaborates with the program

September 10, 2021

Teaching Scholars Program Graduates 22 Faculty and Welcomes 19 New Scholars in its 20th Year

September 9, 2021

The Triangle’s mental health care system shows the strain of 18 months of pandemic, Dr. Meltzer-Brody speaks with News & Observer

September 8, 2021

Dealing with Anger 18 Months into the Pandemic, featuring Dr. Crystal Schiller

September 7, 2021

Welcome Maureen Hayes, MD!

September 1, 2021

Welcome Brittany Selkregg, LCSW!

September 1, 2021